Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Genomma Lab Internacional Sab (LABB MM)
Watchlist
19
Analysis
Health Care
•
Mexico
Genomma Lab Internacional SAB de CV develops, markets, sells and distributes over-the-counter drugs and personal care products.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Macroeconomics
•
13 May 2025 01:02
•
Syndicated
Actinver Research - Consumer Post 1Q25 Update
Soft consumer environment, with weaker conditions at the beginning of the year vs the company’s expectations; a warmer season didn’t help either.
Actinver
Follow
242 Views
Share
bullish
•
Macroeconomics
•
04 Nov 2024 23:01
•
Syndicated
Actinver Research - Consumer post 3Q24: Sales deceleration while trying to protect margins
Having recently launched our Food & Bev coverage (link to report here), we reiterate our Outperform ratings in beverage companies AC (PT down to...
Actinver
Follow
257 Views
Share
bullish
•
Genomma Lab Internacional Sab
•
13 Aug 2025 22:00
•
Syndicated
Actinver Research - Genomma Lab 4Q24: Model Update Post 2Q25
We reiterate our Outperform rating, while slightly lowering our PT to P$29 (from P$30) post quiet period, as we continue to see meaningful...
Actinver
Follow
236 Views
Share
bullish
•
Genomma Lab Internacional Sab
•
18 Mar 2025 22:00
•
Syndicated
Actinver Research - Genomma Lab 4Q24: Strong finish and positive outlook
Revenues of P$4.7bn grew 32.4% YoY, supported by healthy growth across all regions and FX tailwinds (e.g., U.S. sales grew 1.8% in local currency,...
Actinver
Follow
265 Views
Share
bullish
•
Genomma Lab Internacional Sab
•
27 Feb 2025 12:00
•
Syndicated
Actinver Research - Genomma Lab 4Q24: Healthy finish of the year (Quick View)
Revenues of P$4.7bn grew 32.4% YoY, supported by healthy growth across all regions. Sales in Mexico were in line with our estimates, while in...
Actinver
Follow
305 Views
Share
Previous
1
2
3
4
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x